WHO ICTRP trial
Does Nebulised Lignocaine Reduce Children's Pain When a Nasogastric Tube is…
ACTRN12607000156482 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12607000156482 |
|---|---|
| Public title | Does Nebulised Lignocaine Reduce Children's Pain When a Nasogastric Tube is Inserted? |
| Scientific title | Randomised Controlled Trial of Nebulised Lignocaine Versus Placebo for Relief of Pain of Nasogastric Tube Insertion in Children. |
| Primary sponsor | Royal Children's Hospital (Emergency Department) |
| Secondary sponsors | Murdoch Children's Research Institute (MCRI) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Australia |
| Conditions | Pain and distress associated with nasogastric tube insertion in children.; Pain and distress associated with nasogastric tube insertion in children.;Other - |
| Interventions | The trial solution (comprising aqueous 2% Lignocaine at 4mg/kg dose in total 5mls trial solution in the experimental group versus 5mls normal saline in the control group) will be administered using a face mask and a compressed gas-powered… |
| Registration date | Jun 3, 2007 |
| Target size | 52 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: